KEQU · Kewaunee Scientific Corp /De/ - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69.40M | $70.10M | $71.10M | $47.76M | $67.17M | $48.39M | $50.44M | $46.78M | $49.84M | $54.56M |
| Cost of Revenue | $50.85M | $50.38M | $50.17M | $33.81M | $48.79M | $35.91M | $36.97M | $34.75M | $37.92M | $45.86M |
| Gross Profit | $18.55M | $19.72M | $20.93M | $13.95M | $18.38M | $12.49M | $13.47M | $12.03M | $11.91M | $8.70M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | $15.96M | $15.61M | $16.12M | $9.52M | $16.13M | $9.91M | $8.36M | $8.22M | $8.11M | $7.95M |
| D&A | $1.56M | $806.0K | $1.55M | - | - | $815.0K | - | - | $718.0K | - |
| Operating Income | $2.58M | $4.11M | $4.81M | $4.43M | $2.25M | $2.58M | $5.11M | $3.81M | $3.81M | $755.0K |
| Interest Expense | $1.11M | $1.06M | $1.06M | $442.0K | $1.14M | $472.0K | $372.0K | $411.0K | $430.0K | $370.0K |
| Income Tax | $528.0K | $915.0K | $761.0K | $916.0K | ($108.0K) | $192.0K | $2.02M | $982.0K | $897.0K | $570.0K |
| Net Income | $692.0K | $2.44M | $3.09M | $3.01M | $1.35M | $2.19M | $2.73M | $2.52M | $2.47M | ($243.0K) |
| EPS - Basic | $0.24 | $0.85 | $1.08 | $1.05 | $0.47 | $0.77 | $0.94 | $0.87 | $0.87 | ($0.09) |
| EPS - Diluted | $0.23 | $0.82 | $1.04 | $1.01 | $0.45 | $0.74 | $0.93 | $0.85 | $0.86 | ($0.09) |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.15M | $12.59M | $19.49M | $14.94M | $9.45M | $24.21M | $23.27M | $21.31M | $12.70M | $8.08M |
| Accounts Receivable | $54.13M | $59.02M | $56.90M | $62.38M | $57.42M | $43.55M | $45.06M | $41.11M | $42.46M | $46.08M |
| Inventory | $32.91M | $35.50M | $34.92M | $32.85M | $31.56M | $19.29M | $20.68M | $21.84M | $22.13M | $21.89M |
| Accounts Payable | $23.64M | $22.66M | $26.33M | $27.03M | $24.53M | $20.62M | $23.26M | $19.08M | $22.14M | $23.60M |
| Current Assets | $103.58M | $113.64M | $117.15M | $118.36M | $108.61M | $92.70M | $96.82M | $96.16M | $93.52M | $87.92M |
| Total Assets | $175.96M | $189.07M | $193.49M | $194.65M | $189.15M | $132.02M | $134.77M | $126.31M | $124.82M | $118.90M |
| Current Liabilities | $48.78M | $45.81M | $50.49M | $53.71M | $50.17M | $36.69M | $40.78M | $42.14M | $44.23M | $40.05M |
| Long-term Debt | $16.33M | $32.25M | $34.38M | $34.69M | $34.96M | - | - | - | - | - |
| Total Liabilities | $103.43M | $117.36M | $124.62M | $128.41M | $127.03M | $74.50M | $78.56M | $80.96M | $84.28M | $80.41M |
| Stockholders' Equity | $70.67M | $69.85M | $67.08M | $64.46M | $60.80M | $56.02M | $54.76M | $44.08M | $39.43M | $37.41M |
| Retained Earnings | $65.15M | $64.46M | $62.01M | $58.92M | $54.07M | $49.71M | $47.51M | $36.49M | $31.23M | $28.76M |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | $5.79M | - | - | ($794.0K) | - | - | $8.17M | - |
| Investing Cash Flow | - | - | ($771.0K) | - | - | ($278.0K) | - | - | ($1.65M) | - |
| Financing Cash Flow | - | - | ($1.46M) | - | - | $343.0K | - | - | $1.31M | - |
| CapEx | $689.0K | $683.0K | $771.0K | - | - | $278.0K | - | - | $1.65M | - |
| Free Cash Flow | - | - | $5.02M | - | - | ($1.07M) | - | - | $6.52M | - |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 26.7% | 28.1% | 29.4% | 29.2% | 27.4% | 25.8% | 26.7% | 25.7% | 23.9% | 15.9% |
| Operating margin | 3.7% | 5.9% | 6.8% | 9.3% | 3.3% | 5.3% | 10.1% | 8.1% | 7.6% | 1.4% |
| EBITDA margin | 6.0% | 7.0% | 8.9% | - | - | 7.0% | - | - | 9.1% | - |
| Net margin | 1.0% | 3.5% | 4.3% | 6.3% | 2.0% | 4.5% | 5.4% | 5.4% | 5.0% | -0.4% |
| Free cash flow margin | - | - | 7.1% | - | - | -2.2% | - | - | 13.1% | - |
| FCF / Net income | - | - | 1.62 | - | - | -0.49 | - | - | 2.63 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 43.3% | 27.2% | 19.7% | 23.3% | -8.7% | 8.1% | 42.4% | 28.0% | 26.6% | 174.3% |
| Return on assets | 0.4% | 1.3% | 1.6% | 1.5% | 0.7% | 1.7% | 2.0% | 2.0% | 2.0% | -0.2% |
| Return on equity | 1.0% | 3.5% | 4.6% | 4.7% | 2.2% | 3.9% | 5.0% | 5.7% | 6.3% | -0.6% |
| Return on invested capital | 1.7% | 2.9% | 3.8% | 3.4% | 2.3% | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.12 | 2.48 | 2.32 | 2.20 | 2.16 | 2.53 | 2.37 | 2.28 | 2.11 | 2.20 |
| Quick ratio | 1.45 | 1.71 | 1.63 | 1.59 | 1.54 | 2.00 | 1.87 | 1.76 | 1.61 | 1.65 |
| Cash ratio | 0.17 | 0.27 | 0.39 | 0.28 | 0.19 | 0.66 | 0.57 | 0.51 | 0.29 | 0.20 |
| Leverage | ||||||||||
| Debt / Equity | 0.23 | 0.46 | 0.51 | 0.54 | 0.58 | - | - | - | - | - |
| Debt / Assets | 0.09 | 0.17 | 0.18 | 0.18 | 0.18 | - | - | - | - | - |
| Debt / EBITDA | 3.94 | 6.56 | 5.41 | - | - | - | - | - | - | - |
| Interest coverage | 2.3x | 3.9x | 4.5x | 10.0x | 2.0x | 5.5x | 13.7x | 9.3x | 8.9x | 2.0x |
| Equity multiplier | 2.49 | 2.71 | 2.88 | 3.02 | 3.11 | 2.36 | 2.46 | 2.87 | 3.17 | 3.18 |
| Liabilities / Assets | 0.59 | 0.62 | 0.64 | 0.66 | 0.67 | 0.56 | 0.58 | 0.64 | 0.68 | 0.68 |
| Efficiency | ||||||||||
| Asset turnover | 0.39 | 0.37 | 0.37 | 0.25 | 0.36 | 0.37 | 0.37 | 0.37 | 0.40 | 0.46 |
| Inventory turnover | 1.55 | 1.42 | 1.44 | 1.03 | 1.55 | 1.86 | 1.79 | 1.59 | 1.71 | 2.10 |
| Days sales outstanding | 285d | 307d | 292d | 477d | 312d | 328d | 326d | 321d | 311d | 308d |
| Days inventory outstanding | 236d | 257d | 254d | 355d | 236d | 196d | 204d | 229d | 213d | 174d |
| Days payable outstanding | 170d | 164d | 192d | 292d | 184d | 210d | 230d | 200d | 213d | 188d |
| Cash conversion cycle | 351d | 400d | 355d | 540d | 365d | 315d | 301d | 350d | 311d | 295d |
| Valuation | ||||||||||
| P / E | 171.9x | 51.0x | 53.2x | 31.4x | 142.9x | 75.2x | 38.4x | 33.1x | 18.2x | - |
| P / B | 1.7x | 1.8x | 2.4x | 1.5x | 3.2x | 2.9x | 1.9x | 1.9x | 1.1x | 1.2x |
| P / S | 1.7x | 1.8x | 2.3x | 2.0x | 2.9x | 3.4x | 2.1x | 1.8x | 0.9x | 0.8x |
| EV / EBITDA | 30.4x | 29.5x | 28.1x | - | - | 41.5x | - | - | 7.2x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 3.3% | 46.8% | 46.9% | -5.3% | 43.6% | -2.9% | -7.6% | -23.1% | -0.6% | 39.8% |
| Revenue CAGR (3y) | 4.5% | 8.7% | 12.4% | 7.0% | 18.2% | 7.0% | 8.9% | 12.0% | 11.0% | 11.2% |
| Revenue CAGR (5y) | 15.8% | 12.4% | 14.3% | 3.8% | 14.4% | 4.2% | - | 7.6% | 3.4% | 5.6% |
| Gross profit growth (YoY) | 0.9% | 41.3% | 67.6% | 3.6% | 52.8% | 4.8% | 54.8% | 16.4% | 92.3% | 141.9% |
| Operating income growth (YoY) | 14.8% | -7.4% | 86.8% | -13.2% | -40.9% | -32.4% | 576.7% | 65.2% | - | - |
| Net income growth (YoY) | -48.9% | -18.7% | 41.0% | 10.1% | -46.3% | -11.4% | - | 248.7% | - | 92.2% |
| EPS growth (YoY) | -48.9% | -18.8% | 40.5% | 8.6% | -47.1% | -14.0% | - | 240.0% | - | 91.9% |
| EPS CAGR (3y) | -2.7% | - | - | - | - | - | - | 204.9% | - | - |
| EPS CAGR (5y) | 50.3% | - | - | - | - | 34.2% | - | - | 11.5% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | 97.8% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 16.2% | 8.4% | 19.7% | 17.7% | 37.9% | 42.1% | 46.4% | 24.7% | 13.7% | 4.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-04-30.
Business segments
$240.47M totalDomestic Operations$179.40M · 74.6%
International Operations$61.07M · 25.4%
Geographic
$7.73M totalNon Us$7.73M · 100.0%
Peer comparison
Same SIC group: Laboratory Apparatus & Furniture
| Company | Revenue (last FY) | Net margin | ROE |
|---|---|---|---|
| THMO | - | - | - |
Comparing KEWAUNEE SCIENTIFIC CORP /DE/ against the 1 most active filer in the same SIC group.
Dividends
$0.00/share trailing 12 months
| Ex-date | Per share |
|---|---|
| Sep 9, 2019 | $0.1900 |
| Jun 6, 2019 | $0.1900 |
| Mar 8, 2019 | $0.1900 |
| Dec 3, 2018 | $0.1900 |
| Sep 10, 2018 | $0.1900 |
| Jun 7, 2018 | $0.1700 |
| Mar 8, 2018 | $0.1700 |
| Dec 1, 2017 | $0.1700 |
| Sep 8, 2017 | $0.1700 |
| Jun 8, 2017 | $0.1500 |
| Mar 8, 2017 | $0.1500 |
| Dec 1, 2016 | $0.1500 |
| Sep 8, 2016 | $0.1500 |
| Jun 9, 2016 | $0.1300 |
| Mar 10, 2016 | $0.1300 |
| Dec 3, 2015 | $0.1300 |
| Sep 3, 2015 | $0.1300 |
| Jun 10, 2015 | $0.1200 |
| Mar 11, 2015 | $0.1200 |
| Dec 3, 2014 | $0.1200 |
| Sep 4, 2014 | $0.1200 |
| Jun 4, 2014 | $0.1100 |
| Mar 12, 2014 | $0.1100 |
| Dec 4, 2013 | $0.1100 |